GLP-1 receptor agonists and the risk for cancer: A meta-analysis of randomized controlled trials. Silverii GA, Marinelli C, Bettarini C, Del Vescovo GG, et al. Diabetes Obes Metab 2025;27:4454-4468.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Silverii GA, Marinelli C, Bettarini C, Del Vescovo GG, et al. GLP-1 receptor agonists and the risk for cancer: A meta-analysis of randomized controlled trials. Diabetes Obes Metab 2025;27:4454-4468.
PMID: 40437949